DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03125265

Enrollment

9757

Registered

2017-04-24

Start date

2014-01-05

Completion date

2016-01-31

Last updated

2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Habit, End Stage Renal Disease

Keywords

nutrition, hemodialysis, mortality, omega 3

Brief summary

The DIETary intake, death and hospitalisation in adults with end-stage kidney disease treated with HaemoDialysis (DIET-HD) study is a multinational prospective cohort study designed to evaluate the association between nutrition and dietary patterns and health outcomes in prevalent adult haemodialysis patients in Europe and South America.

Interventions

OTHERdietary intake of omega-3 and omega-6 polyunsaturated fatty acids

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* End-stage kidney disease * Long-term haemodialysis for at least the previous 90 days * 18 years or older * Treating team agrees to the patient's involvement in the study * Participant willing to provide written and informed consent.-

Exclusion criteria

* significant neurocognitive disability or medical comorbidity that would preclude them from understanding the dietary questionnaire even if assisted * a life expectancy less than 6 months according to their treating physician * planned kidney transplantation within 6 months of baseline

Design outcomes

Primary

Measure	Time frame	Description
Cardiovascular mortality	12 months since baseline dietary evaluation	Defined as sudden death or death attributed to acute myocardial infarction, pericarditis, atherosclerotic heart disease, cardiomyopathy, cardiac arrhythmia, cardiac arrest, valvular heart disease, pulmonary edema, or congestive cardiac failure

Secondary

Measure	Time frame
All-cause mortality	12 months since baseline dietary evaluation
Infection-related mortality	12 months since baseline dietary evaluation
All-cause and cardiovascular related hospitalisation	12 months since baseline dietary evaluation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026